PROCEPT BioRobotics Corp.
(NASDAQ: PRCT)

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

35.430

+2.250 (+6.78%)
Range 33.010 - 36.035   (9.16%)
Open 33.440
Previous Close 33.180
Bid Price 31.440
Bid Volume 8
Ask Price 34.470
Ask Volume 8
Volume 2,376,401
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis